Depression and Type 2 Diabetes
Herausgeber: Ismail, Khalida; Licinio, Julio; Bornstein, Stefan R; Barthel, Andreas
Depression and Type 2 Diabetes
Herausgeber: Ismail, Khalida; Licinio, Julio; Bornstein, Stefan R; Barthel, Andreas
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Diabetes and Type-2-Diabetes is a unique resource examining the frequent co-morbidity of diabetes and depression.
Andere Kunden interessierten sich auch für
- Ralph Sanchez MtcmThe Diabetic Brain in Alzheimer's Disease: How Insulin Resistance in Type 2 Diabetes and "Type 3 Diabetes" Triggers Your Risk for Alzheimer's and How17,99 €
- Depression as a Systemic Illness102,99 €
- Ann M SteffenTreating Later-Life Depression93,99 €
- Internet of Things and Machine Learning for Type I and Type II Diabetes177,99 €
- Steven M StrakowskiDepression148,99 €
- Integrative Therapies for Depression68,99 €
- Sidney H KennedyTreating Depression Effectively113,99 €
-
-
-
Diabetes and Type-2-Diabetes is a unique resource examining the frequent co-morbidity of diabetes and depression.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 272
- Erscheinungstermin: 30. Oktober 2018
- Englisch
- Abmessung: 231mm x 155mm x 18mm
- Gewicht: 417g
- ISBN-13: 9780198789284
- ISBN-10: 0198789289
- Artikelnr.: 51250582
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Oxford University Press
- Seitenzahl: 272
- Erscheinungstermin: 30. Oktober 2018
- Englisch
- Abmessung: 231mm x 155mm x 18mm
- Gewicht: 417g
- ISBN-13: 9780198789284
- ISBN-10: 0198789289
- Artikelnr.: 51250582
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Khalida Ismail, Professor of Psychiatry and Medicine, Department of Psychological Medicine Institute of Psychiatry, Psychology and Neuroscience King's College London, London, UK, Andreas Barthel, Associate Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany , Stefan R. Bornstein, Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, Julio Licinio, Deputy Director, College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA
* 1: Stefan F. Bornstein, Andreas Birkenfeld, and Julio Licinio: Global
burden of diabetes and depression
* 2: Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W.
Penninx: A lifecourse approach to understanding the association
between depression and type 2 diabetes
* 3: Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar:
MicroRNAs as novel biomarkers in depression, diabetes and
cardiovascular diseases
* 4: Carol Kan and Ma-Li Wong: Genetics
* 5: Calum D. Moulton and John Pickup: Innate immunity and inflammation
in type 2 diabetes-associated depression
* 6: Allan H. Young and Mario F. Jurena: Hypothalamic-Pituitary-Adrenal
(HPA) axis
* 7: Carla Petrella, Giuseppe Nistico, and Robert Nistico: Gut-brain
axis: physiology
* 8: Norbert Hermanns, Marijke Bremmer, and Frank Snoek: Diabetes
distress
* 9: Calum Moulton and Clive Ballard: The association between
depression and cognitive impairment in type 2 diabetes
* 10: Frank Petrak and Bonnie Röhrig: Treatment of depression in type 2
diabetes
* 11: Andreas Barthel and Michael Bauer: Risks and benefits of
psychotropics
* 12: Lidia Castagneto Gissey, James Casella Mariolo, Geltrude
Mingrone, and Francesco Rubino: Metabolic surgery and depression
* 13: Calum Moulton: Novel pharmacological targets
* 14: Harold Lebovitz and Shlomo Ben Haim: Novel technologies
* 15: Christopher Garrett: Current and emerging psychological models
* 16: Eleanor M Scott and Gregory Potter: Targeting the circadian
rhythm
* 17: Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew: Cultural and
global perspectives
* 18: Peter Schwarz and Patrick Timpel: National and international
policy initiatives on multi-morbidity
burden of diabetes and depression
* 2: Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W.
Penninx: A lifecourse approach to understanding the association
between depression and type 2 diabetes
* 3: Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar:
MicroRNAs as novel biomarkers in depression, diabetes and
cardiovascular diseases
* 4: Carol Kan and Ma-Li Wong: Genetics
* 5: Calum D. Moulton and John Pickup: Innate immunity and inflammation
in type 2 diabetes-associated depression
* 6: Allan H. Young and Mario F. Jurena: Hypothalamic-Pituitary-Adrenal
(HPA) axis
* 7: Carla Petrella, Giuseppe Nistico, and Robert Nistico: Gut-brain
axis: physiology
* 8: Norbert Hermanns, Marijke Bremmer, and Frank Snoek: Diabetes
distress
* 9: Calum Moulton and Clive Ballard: The association between
depression and cognitive impairment in type 2 diabetes
* 10: Frank Petrak and Bonnie Röhrig: Treatment of depression in type 2
diabetes
* 11: Andreas Barthel and Michael Bauer: Risks and benefits of
psychotropics
* 12: Lidia Castagneto Gissey, James Casella Mariolo, Geltrude
Mingrone, and Francesco Rubino: Metabolic surgery and depression
* 13: Calum Moulton: Novel pharmacological targets
* 14: Harold Lebovitz and Shlomo Ben Haim: Novel technologies
* 15: Christopher Garrett: Current and emerging psychological models
* 16: Eleanor M Scott and Gregory Potter: Targeting the circadian
rhythm
* 17: Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew: Cultural and
global perspectives
* 18: Peter Schwarz and Patrick Timpel: National and international
policy initiatives on multi-morbidity
* 1: Stefan F. Bornstein, Andreas Birkenfeld, and Julio Licinio: Global
burden of diabetes and depression
* 2: Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W.
Penninx: A lifecourse approach to understanding the association
between depression and type 2 diabetes
* 3: Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar:
MicroRNAs as novel biomarkers in depression, diabetes and
cardiovascular diseases
* 4: Carol Kan and Ma-Li Wong: Genetics
* 5: Calum D. Moulton and John Pickup: Innate immunity and inflammation
in type 2 diabetes-associated depression
* 6: Allan H. Young and Mario F. Jurena: Hypothalamic-Pituitary-Adrenal
(HPA) axis
* 7: Carla Petrella, Giuseppe Nistico, and Robert Nistico: Gut-brain
axis: physiology
* 8: Norbert Hermanns, Marijke Bremmer, and Frank Snoek: Diabetes
distress
* 9: Calum Moulton and Clive Ballard: The association between
depression and cognitive impairment in type 2 diabetes
* 10: Frank Petrak and Bonnie Röhrig: Treatment of depression in type 2
diabetes
* 11: Andreas Barthel and Michael Bauer: Risks and benefits of
psychotropics
* 12: Lidia Castagneto Gissey, James Casella Mariolo, Geltrude
Mingrone, and Francesco Rubino: Metabolic surgery and depression
* 13: Calum Moulton: Novel pharmacological targets
* 14: Harold Lebovitz and Shlomo Ben Haim: Novel technologies
* 15: Christopher Garrett: Current and emerging psychological models
* 16: Eleanor M Scott and Gregory Potter: Targeting the circadian
rhythm
* 17: Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew: Cultural and
global perspectives
* 18: Peter Schwarz and Patrick Timpel: National and international
policy initiatives on multi-morbidity
burden of diabetes and depression
* 2: Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W.
Penninx: A lifecourse approach to understanding the association
between depression and type 2 diabetes
* 3: Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar:
MicroRNAs as novel biomarkers in depression, diabetes and
cardiovascular diseases
* 4: Carol Kan and Ma-Li Wong: Genetics
* 5: Calum D. Moulton and John Pickup: Innate immunity and inflammation
in type 2 diabetes-associated depression
* 6: Allan H. Young and Mario F. Jurena: Hypothalamic-Pituitary-Adrenal
(HPA) axis
* 7: Carla Petrella, Giuseppe Nistico, and Robert Nistico: Gut-brain
axis: physiology
* 8: Norbert Hermanns, Marijke Bremmer, and Frank Snoek: Diabetes
distress
* 9: Calum Moulton and Clive Ballard: The association between
depression and cognitive impairment in type 2 diabetes
* 10: Frank Petrak and Bonnie Röhrig: Treatment of depression in type 2
diabetes
* 11: Andreas Barthel and Michael Bauer: Risks and benefits of
psychotropics
* 12: Lidia Castagneto Gissey, James Casella Mariolo, Geltrude
Mingrone, and Francesco Rubino: Metabolic surgery and depression
* 13: Calum Moulton: Novel pharmacological targets
* 14: Harold Lebovitz and Shlomo Ben Haim: Novel technologies
* 15: Christopher Garrett: Current and emerging psychological models
* 16: Eleanor M Scott and Gregory Potter: Targeting the circadian
rhythm
* 17: Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew: Cultural and
global perspectives
* 18: Peter Schwarz and Patrick Timpel: National and international
policy initiatives on multi-morbidity